Should You Buy Canada Goose Holdings Inc. Ahead of Earnings?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) has seen tremendous growth in its first year on the TSX, but can investors expect that to continue?

| More on:

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) has been listed on the TSX for almost a year now, and the results have been encouraging. In less than a year, the stock price has doubled, and the company has continued to show incredible growth. Canada Goose will release its third-quarter results in early February, and investors may be wondering if now is a good time to buy.

Let’s take a closer look at how Canada Goose has done, where its value is today, and whether the stock is a good buy ahead of its upcoming earnings.

Growth has been strong, but can it last?

In its most recent quarter, sales were up more than 34%, and net income nearly doubled from a year ago. However, in two of the past three quarters, the company has finished in the red. In fiscal 2017, the company’s revenues broke through $400 million and were up 39% from 2016.

Over the past three years, sales have more than doubled and are on pace for another great year. Revenue in the trailing 12 months has totaled $460 million. Canada Goose has been averaging a profit margin of a little less than 9%.

The problem I see is that even though the company had a strong Q2, there are several warning flags for investors. Growing inventory and debt levels are not things that should be ignored by investors, and you only need to look as far as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) to see the problems that can occur when a company gets saddled with too much debt.

The retail world has been a tough one, and while Canada Goose is showing tremendous growth so far, it’s hard to envision a big market for $1,000 parkas and other high-priced clothing items.

Stock is not a value buy

At a book value of just over $1.6, Canada Goose is trading 27 times that amount. With limited earnings, the stock is also at a price-to-earnings multiple north of 100. Value investors will not have much attraction to this stock, and Canada Goose is only a good buy at the price if you see the growth continuing, which I’m skeptical of.

Should you buy before Q3?

The company’s upcoming earnings is its peak season, and a year ago sales totaled more than $209 million, which was a 63% increase from the previous quarter. A similar jump this year would send sales to over $280 million.

However, it’s this seasonality that also possesses a big risk. A warmer-than-normal winter could wreak havoc on the company’s financials. The company effectively has two off-peak quarters: those ending in March and June. Revenue during these quarters combined for less than $80 million this past year, less than half of Q2 totals.

Canada Goose is not a stock that I would consider buying when you consider its high valuation and limited market potential. While the stock may have generated significant returns already, that makes me concerned that there might not be much upside left at the current value.

There might be some decent returns that could be achieved in the short term, but this is not a stock that I’d suggest leaving in your portfolio for a long period of time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

TFSA 101: Earn $1,430 Per Year Tax-Free

Are you new to the TFSA? Here are three strategies to optimize its tax benefits to earn annual passive tax-free…

Read more »

concept of real estate evaluation
Dividend Stocks

Buy 1,154 Shares of This Top Dividend Stock for $492.54/Month in Passive Income

This dividend stock can pay out top cash every month, sure, but has even more to look forward to.

Read more »

chart reflected in eyeglass lenses
Energy Stocks

Best Stock to Buy Right Now: Canadian Natural Resources vs Cenovus?

Want to invest in Canadian energy? Canadian Natural Resources and Cenovus Energy are two of the largest, but which one…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use a TFSA to Create $1,650 in Passive Income for Decades! 

If you spend a lot, consider the dividend route to create a passive income for decades. The TFSA can be…

Read more »

Hourglass and stock price chart
Dividend Stocks

This 7.1% Dividend Stock Pays Cash Every Month

This dividend stock is a solid choice for investors looking for long-term cash from the healthcare sector, with monthly dividends…

Read more »

Man looks stunned about something
Investing

3 CRA Red Flags for RRSP Millionaires

The RRSP is a great tool, but only if used properly. Watch out for these red flags.

Read more »

Investing

My 3 Favourite Canadian Stocks to Buy Right Now

Alimentation Couche-Tard (TSX:ATD) and another great value play that could be worth buying before the holidays.

Read more »

Canadian stocks are rising
Dividend Stocks

2 No-Brainer Real Estate Stocks to Buy Right Now for Less Than $500 

Do you have $500 and are wondering which stocks to buy? These no-brainer real estate stocks could be good additions…

Read more »